Board meeting on 27 October 2026 to consider Q2 and H1 FY27 results
Board meeting scheduled for Tuesday, 27th October 2026.
By ScoutQuest · · 2 min read
- Board Meeting Date
- Tuesday, 27th October 2026
- Agenda
- un-audited standalone and consolidated financial results for the quarter and half year ended 30th September 2026
- Trading Window Closure
- till 48 hours after the results are declared, i.e. Thursday, 29th October 2026 (inclusive)
What the update says
Morepen Laboratories has given notice to the National Stock Exchange and BSE that a meeting of its Board of Directors is scheduled to be held on Tuesday, 27th October 2026. The stated agenda is, among other things, to consider and approve the un-audited standalone and consolidated financial results of the company for the quarter and half year ended 30th September 2026.
Why this matters
- This is the notice that tells the market when the company's Q2 and first-half numbers for FY27 will be taken up by the Board for approval.
- The results will be in two forms: standalone, which reflects the company on its own, and consolidated, which combines the company with its subsidiaries. Investors typically look at the consolidated numbers to judge the whole group.
- The numbers covered are for the quarter ended 30th September 2026 and the half year ended on the same date, so the update sets up the second set of results for the current financial year.
- These are described as un-audited results.
Trading window
- The company had earlier written on 28th September 2026 about the closure of the trading window under its Code of Conduct to Regulate, Monitor and Report of Trading by Insiders.
- That window will continue to remain closed till 48 hours after the declaration of the financial results, i.e. Thursday, 29th October 2026 (inclusive).
- This applies to all Designated Persons and their immediate relatives.
- In simple terms, a trading window is a period when company insiders are not allowed to buy or sell the company's shares, so that people with advance access to results do not trade on information the market does not yet have. It normally reopens only after the results have been made public and a short cooling-off period has passed.
What to take away
- The update is a scheduling notice. It tells you when the Board will meet to approve the Q2 and H1 FY27 results, and when the insider trading window is expected to reopen.
- The actual performance figures for the quarter and half year are part of the results themselves, which will be considered at the meeting scheduled on 27th October 2026.
What investors can watch
- The standalone and consolidated results once approved by the Board.
- The reopening of the trading window after Thursday, 29th October 2026 (inclusive), which is 48 hours after the declaration of the financial results.
Also from Morepen Laboratories
Analysts gave a short-term target and hold recommendation for Morepen Laboratories ahead of its results
23 Oct 2026
High Court quashes GST show cause notice seeking ₹117.94 crore recovery
14 Oct 2026
First U.S. ANDA submitted to USFDA for Sitagliptin Tablets in three strengths
28 Sep 2026
More numbers
- Trading window closure period after declaration of results48 hours
Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.